See more : Mercato Partners Acquisition Corporation (MPRA) Income Statement Analysis – Financial Results
Complete financial analysis of Fairchem Organics Limited (FAIRCHEMOR.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fairchem Organics Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Monami Co., Ltd. (005360.KS) Income Statement Analysis – Financial Results
- North Mountain Merger Corp. (NMMCU) Income Statement Analysis – Financial Results
- DIC India Limited (DICIND.NS) Income Statement Analysis – Financial Results
- Technology One Limited (TNE.AX) Income Statement Analysis – Financial Results
- Southeast Asia Properties & Finance Limited (0252.HK) Income Statement Analysis – Financial Results
Fairchem Organics Limited (FAIRCHEMOR.BO)
About Fairchem Organics Limited
Fairchem Organics Limited manufactures and sells specialty oleo chemicals and intermediate nutraceuticals in India, East Asia, the Middle East, and North America. It provides nutraceuticals comprising natural and mixed tocopherol and sterol concentrates; and oleo chemicals, such as dimer, monobasic, linoleic/soya fatty, monomer, palmitic, and distilled fatty acid products, as well as residues. The company was incorporated in 2019 and is based in Ahmedabad, India. Fairchem Organics Limited operates as a subsidiary of FIH Mauritius Investments Ltd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 6.18B | 6.47B | 6.42B | 3.96B | 3.06B |
| Cost of Revenue | 5.05B | 4.96B | 4.65B | 2.70B | 2.11B |
| Gross Profit | 1.13B | 1.51B | 1.78B | 1.25B | 945.33M |
| Gross Profit Ratio | 18.26% | 23.30% | 27.65% | 31.69% | 30.91% |
| Research & Development | 1.63M | 1.95M | 1.94M | 1.54M | 2.60M |
| General & Administrative | 44.01M | 29.56M | 21.54M | 70.69M | 25.30M |
| Selling & Marketing | 73.68M | 71.66M | 72.02M | 59.15M | 38.28M |
| SG&A | 117.69M | 101.22M | 93.57M | 129.84M | 63.57M |
| Other Expenses | 1.01B | 4.97M | 513.00K | 62.00K | 1.19M |
| Operating Expenses | 1.13B | 865.02M | 797.41M | 631.58M | 518.12M |
| Cost & Expenses | 5.62B | 5.83B | 5.44B | 3.34B | 2.63B |
| Interest Income | 423.00K | 124.00K | 373.00K | 2.31M | 1.25M |
| Interest Expense | 42.39M | 62.62M | 68.56M | 69.78M | 65.79M |
| Depreciation & Amortization | 92.78M | 81.52M | 71.31M | 65.73M | 59.60M |
| EBITDA | 681.14M | 729.68M | 1.05B | 688.06M | 548.59M |
| EBITDA Ratio | 11.02% | 11.29% | 16.37% | 17.45% | 18.07% |
| Operating Income | 582.14M | 649.99M | 985.22M | 624.78M | 423.93M |
| Operating Income Ratio | 9.42% | 10.05% | 15.34% | 15.79% | 13.86% |
| Total Other Income/Expenses | -36.18M | -64.06M | -65.78M | -69.17M | -3.03M |
| Income Before Tax | 545.96M | 585.93M | 912.40M | 555.61M | 424.18M |
| Income Before Tax Ratio | 8.83% | 9.06% | 14.21% | 14.04% | 13.87% |
| Income Tax Expense | 140.96M | 150.91M | 233.34M | 130.76M | 77.14M |
| Net Income | 405.00M | 435.02M | 679.06M | 424.85M | 347.04M |
| Net Income Ratio | 6.55% | 6.72% | 10.57% | 10.73% | 11.35% |
| EPS | 31.10 | 33.41 | 52.15 | 32.63 | 26.65 |
| EPS Diluted | 31.11 | 33.41 | 52.15 | 32.63 | 26.65 |
| Weighted Avg Shares Out | 13.02M | 13.02M | 13.02M | 13.02M | 13.02M |
| Weighted Avg Shares Out (Dil) | 13.02M | 13.02M | 13.02M | 13.02M | 13.02M |
Source: https://incomestatements.info
Category: Stock Reports